Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Data, Analytics & AI · CoCoPoP Framework

The CoCoPoP Framework: Condition, Context and Population in Prevalence Reviews

Prevalence and incidence questions involve neither an intervention nor a comparator. For this reason, methodological work by the Joanna Briggs Institute on this question type produced a three-part framework — Condition, Context, Population — paired with a dedicated critical appraisal tool rather than an adapted PICO checklist.

Pubrica AcademyWritten by an evidence synthesis methodologist Reviewed byan epidemiology reviewer Published10 October 2026 Last checked10 October 2026 Reading time11 minutes Sources17 peer-reviewed

CoCoPoP structures a prevalence or incidence research question around three elements: Condition (the health state, disease or phenomenon being measured), Context (the setting, time period or circumstances in which the measurement is taken), and Population (the group being measured). It exists because prevalence questions, of the form “how common is Condition X in Population Y,” differ fundamentally in structure from intervention-effectiveness questions: no treatment is tested and there is no comparator group, so the Intervention and Comparison elements of PICO are inapplicable. The methodological work of the Joanna Briggs Institute on systematic reviews of prevalence and incidence data, led by Zachary Munn and colleagues, developed both the question structure and a corresponding critical appraisal tool specifically for this question type.

CoCoPoP at a glance

Stands for
Condition, Context, Population
Source
JBI methodological work on prevalence and incidence reviews, Munn et al. (2014, 2015)111
Best for
Systematic reviews asking how common a condition is (prevalence) or how often new cases arise (incidence)
Not for
Effectiveness questions with a comparator (use PICO) or broad mapping questions (use PCC)
Appraisal
The JBI checklist for prevalence studies, not an intervention-study tool2
Reading time
About 11 minutes, with 3 figures and 5 tables

Learning objectives

  • Why prevalence and incidence questions do not fit the structure of PICO
  • The three CoCoPoP elements, with a worked example
  • Why prevalence studies require a dedicated critical appraisal tool rather than one adapted from another design

Common misconceptions

  • “A prevalence question can just use PICO with the Intervention and Comparison slots left blank.” The methodological guidance of the Joanna Briggs Institute for prevalence and incidence systematic reviews developed a dedicated critical appraisal tool specifically because the standard quality-appraisal criteria designed for intervention studies (randomization, blinding, comparator group) do not apply to a prevalence study, and leaving the Intervention and Comparison elements of PICO blank does not resolve the underlying mismatch between the question type and the appraisal method.

Incompatibility of prevalence questions with PICO

A prevalence question asks how common a condition is in a population at a given time or place, and an incidence question asks how frequently new cases arise over a period; neither involves testing an intervention against a comparator, which is the core structure on which PICO is based. The methodological work of Munn and colleagues on systematic reviews addressing prevalence developed a critical appraisal tool specifically because existing checklists, designed for randomized and other comparative intervention studies, ask about randomization and comparator groups, which do not apply to a study designed solely to measure how common a condition is within a defined group1. This mismatch is the reason why a distinct question-structuring framework, rather than a PICO variant with blank fields, was required for this question type.

The three CoCoPoP elements, with a worked example

Condition denotes the health state, disease, symptom or phenomenon whose prevalence or incidence is being measured, defined with sufficient precision to correspond to the way it is diagnosed or detected in the included studies. Context denotes the setting, geographic location, time period or circumstances to which the measurement applies, since prevalence is seldom a fixed, universal value and varies substantially by setting and period. Population denotes the specific group within which the measurement is taken, defined by demographic, clinical or other relevant characteristics. Applied to a question about how common postpartum depression is among first-time mothers in low-income countries within the first six months after birth, Condition is postpartum depression, Context is low-income countries within six months postpartum, and Population is first-time mothers. Each element restricts the eventual search and appraisal to studies that measured the same condition, in the same kind of setting, within the same group.

CoConditionThe health state, disease, symptom or phenomenon being counted, defined as it is diagnosed or detected
CoContextThe setting, location, time period or circumstances the estimate applies to
PopPopulationThe group in which the measurement is taken, by demographic or clinical characteristics

Combined into one questionHow common is postpartum depression among first-time mothers in low-income countries within six months of birth?

Figure 1. The three CoCoPoP elements combined into a prevalence question, using this article’s illustrative postpartum depression example.

What each CoCoPoP element should specify

ElementAsk yourselfTypical contentAvoid
ConditionWhat exactly is being counted, and how is it diagnosed?A named diagnosis with criteria or a threshold, a symptom, a behaviourA loose label that captures studies measuring different things
ContextWhere and when does the estimate apply?Country or region, care setting, calendar period, time since an eventTreating Context as a single keyword; it is usually a filter
PopulationWho was measured?Age, sex, occupation, clinical groupA group so broad that studies sampled substantively different people
Intervention / comparatorDo I need one?Neither; a prevalence question has noneLeaving PICO slots blank instead of switching framework

Weak CoCoPoP question

“How common is depression in mothers?”

No time window, no setting, and a Condition with no diagnostic definition, so studies cannot be compared or pooled.

Strong CoCoPoP question

“What is the prevalence of postpartum depression, diagnosed with a validated instrument, among first-time mothers in low-income countries within six months of birth?”

Each element can be searched and each one sets an eligibility criterion.

Worked example of an incidence question

CoCoPoP applies equally to incidence questions, which concern the rate of new cases over a period rather than the proportion of existing cases at a single point in time. An illustrative question concerns how many new cases of occupational hearing loss arise annually among construction workers exposed to high noise levels on urban building sites. Condition is occupational hearing loss, defined by a specific audiometric threshold so that studies using inconsistent diagnostic criteria can be identified and handled separately. Context is urban construction sites with high ambient noise exposure, over a defined calendar period, since noise regulations and their enforcement have changed over time in many jurisdictions. Population is construction workers with regular high-noise exposure. The distinction between this incidence framing and the earlier prevalence example concerning postpartum depression has practical consequences: an incidence estimate requires studies that recorded new cases arising over a defined period, whereas a prevalence estimate requires only a single cross-sectional measurement, which alters the study designs eligible for inclusion in the review.

The two worked examples, element by element

ElementPrevalence exampleIncidence example
ConditionPostpartum depressionOccupational hearing loss, defined by an audiometric threshold
ContextLow-income countries, within six months of birthUrban construction sites with high ambient noise, over a defined calendar period
PopulationFirst-time mothersConstruction workers with regular high-noise exposure
MeasureProportion of existing cases at one point in timeRate of new cases over a period
Eligible designsCross-sectional surveys can answer itNeeds studies that followed people and recorded new cases

Both examples are illustrative, written for this guide.

Need for a dedicated appraisal tool for prevalence studies

The 2014 paper by Munn and colleagues on developing a critical appraisal tool for prevalence systematic reviews sets out appraisal questions tailored specifically to this question type: whether the sample frame was appropriate to address the target population, whether study participants were sampled in an appropriate way, whether the sample size was adequate, whether the condition was measured using valid, reliable and standardized criteria, and whether the response rate was adequate and, if not, whether the difference between respondents and non-respondents was addressed2. None of these questions has an equivalent in an intervention-study checklist structured around randomization and comparator groups, which is the practical reason why prevalence reviews cannot simply adopt an existing appraisal tool and why the Joanna Briggs Institute developed and published one specifically for this purpose2.

Prevalence appraisal questions compared with intervention-study questions

Prevalence-study question (JBI)Why it matters for a prevalence estimateNearest intervention-study question
Was the sample frame appropriate to the target population?A wrong frame biases the estimate however large the sampleNone; trials ask about randomisation instead
Were participants sampled appropriately?Convenience samples over- or under-represent the conditionAllocation concealment, which does not apply
Was the sample size adequate?Small samples give imprecise proportionsPower for a between-group difference
Was the condition measured with valid, reliable, standard criteria?Different criteria give different prevalence figuresOutcome measurement, but against a comparator
Was the response rate adequate, and were non-responders addressed?Non-response can make a condition look more or less commonLoss to follow-up, which is a different problem

Prevalence questions as listed in this section; the right-hand column is our comparison.

Decisions on statistical pooling of prevalence estimates

Once a CoCoPoP-structured search and appraisal have identified the relevant studies, the reviewer must still decide whether to combine their individual prevalence estimates into a single pooled figure through meta-analysis or to present the range of reported estimates descriptively without pooling. Pooling is most defensible when the included studies measured the Condition using sufficiently similar diagnostic criteria and sampled from a sufficiently similar Context, because pooling studies that measured substantively different conditions, or that drew on substantively different settings and time periods, produces a combined figure that corresponds to no real, interpretable population. A high degree of statistical heterogeneity among the included prevalence estimates, formally detectable through standard heterogeneity statistics, is itself informative, since it indicates that the Context element was not held sufficiently constant across the included studies for a single pooled estimate to be meaningful. In that situation, a narrative or subgroup-stratified presentation of the separate estimates is usually more transparent and more useful to readers than a pooled figure that can be calculated but is difficult to interpret.

Differences between CoCoPoP and the PCC framework

PCC (Population, Concept, Context) is a related three-element framework widely used for scoping reviews, and the two are sometimes confused because both share Population and Context. The difference is scope: PCC’s Concept is deliberately broad, whereas CoCoPoP’s Condition is a measurable state being quantified as a rate. Choose by asking whether the review maps a literature or estimates a figure. Switching framework partway through, in either direction, is reasonable if the switch and the reason for it are documented.

CoCoPoP or PCC?

CoCoPoPPCC
PurposeEstimate a specific, quantifiable rateMap a broad literature
Central elementCondition: a measurable health state or phenomenonConcept: almost any phenomenon, intervention, experience or policy
Example questionHow common is low telehealth adoption among rural primary care practices?What has been published about telehealth adoption in rural health systems?
When to switchEvidence too sparse or heterogeneous for a defensible rate: pivot to PCC and say soThe real question turns out to be a rate: pivot to CoCoPoP and say so

Practical application of CoCoPoP

When CoCoPoP elements are translated into a search strategy, Condition typically generates the most reliable keyword and subject-heading cluster, whereas Context often needs to be applied as a filter on study setting or publication date rather than as a single search term, since prevalence can change substantially within a few years in a rapidly developing field. Population should be defined with sufficient precision to exclude studies measuring prevalence in a substantively different group, while remaining broad enough to capture legitimate variation in how studies described the same population. Reviewers should also decide at the outset whether the review will estimate a single pooled prevalence figure through meta-analysis or synthesize a range of reported figures descriptively, since this choice determines how strictly Context must be held constant across included studies.

Checklist for a CoCoPoP-structured review

  • Define the Condition by the diagnostic criteria or threshold the included studies will have used.
  • Decide whether the question is about prevalence or incidence; this changes the eligible designs.
  • Apply Context as a filter on setting, geography and date, not as one keyword.
  • Define the Population tightly enough to exclude different groups, loosely enough to catch varied descriptions.
  • Appraise studies with the JBI prevalence checklist.
  • Decide in advance whether to pool; report heterogeneity and stratify by Context if it is high.
  • Cite the JBI methodological guidance for prevalence and incidence reviews.11

Takeaway

CoCoPoP is short because a prevalence question is simple in shape. The work lies in defining the Condition precisely and keeping the Context constant enough for the estimates to mean the same thing.

CoCoPoP in published reviews

The JBI working group published its tailored guidance for prevalence and cumulative incidence reviews in 2015, noting that these reviews follow the same structured steps as effectiveness reviews but need tailoring at critical appraisal and synthesis11. Since then, reviews in neurology, occupational health, infectious disease and kidney care have reported using CoCoPoP to set their inclusion criteria. The table describes a selection, using only what each abstract reports.

Published reviews that report using CoCoPoP

ReviewQuestionHow CoCoPoP was used (as reported)Included
Ehtesham et al., 2021, BMC NeurologyGlobal prevalence of familial multiple sclerosisInclusion criteria based on the CoCoPop approach; random-effects meta-analysisRelatives of 16,179 familial MS cases; pooled prevalence 11.8%
Camargo et al., 2021, ChemosphereLegacy chemical contamination in an urban estuarySystematic evidence map with inclusion criteria defined by a CoCoPop statementPeer-reviewed, grey and monitoring data, 1990 to 2019
Henriques et al., 2022, BMJ OpenVitamin D status in active-duty Navy personnelProtocol: CoCoPop used to set inclusion criteria; JBI and Downs and Black appraisalProtocol
Videira et al., 2026, J Med Imaging Radiat SciUse of radiation protective equipment in fluoroscopyFollowed PRISMA and the CoCoPop model; JBI prevalence checklist64 studies
Amoah et al., 2026, Public Health ChallengesQ fever prevalence in AfricaResearch questions and inclusion criteria developed using CoCoPop136 articles
Areri et al., 2026, Health Services InsightsChronic kidney disease screening in sub-Saharan AfricaFollowed the JBI Condition, Context, Population protocol12 studies

Abstracts read on PubMed, 13 November 2026. A selection, not a systematic sample. Camargo et al. show the framework applied beyond human disease, to environmental contamination.

2014Appraisal tool publishedMunn et al., International Journal of Health Policy and Management: critical appraisal tool for prevalence reviews1
2015JBI guidanceMunn et al., International Journal of Evidence-Based Healthcare: methodological guidance for prevalence and cumulative incidence reviews11
2021Meta-analysisEhtesham et al., BMC Neurology: familial multiple sclerosis12
2021Evidence mapCamargo et al., Chemosphere: chemical contamination in Galveston Bay13
2022Review protocolHenriques et al., BMJ Open: vitamin D in Navy personnel14
2026Meta-analysisVideira et al.: radiation protective equipment in fluoroscopy15
2026Systematic reviewAmoah et al., Public Health Challenges: Q fever in Africa16
2026Systematic reviewAreri et al., Health Services Insights: kidney disease screening in sub-Saharan Africa17
Figure 2. From the JBI methodological papers to published reviews that report using CoCoPoP. A selection, not a complete list.

What a CoCoPoP-framed meta-analysis can produce: one published example

Always used (pooled prevalence)Participants in the estimate95% CI
Lead apron
87%
6,383
78 to 94%
Thyroid shield
46%
5,236
26 to 66%
Lead goggles
17%
3,704
8 to 29%

Both bar sets are on linear scales; participant bars are relative to the largest group.

Figure 3. Videira et al. (2026) framed their review with CoCoPoP and appraised studies with the JBI prevalence checklist. Across 64 studies (15,014 participants), consistent use of radiation protection during fluoroscopy varied widely by type of equipment.15

What these reviews show

Most of these reviews pair CoCoPoP with the JBI prevalence checklist, as the framework intends. Two of the 2026 reviews synthesised their findings narratively rather than pooling them, which is consistent with the advice above when Context varies across studies.

Key points

Key points

CoCoPoP structures a prevalence or incidence question around Condition, Context and Population specifically because this question type has no intervention or comparator, and the Joanna Briggs Institute developed both the question structure and a corresponding critical appraisal tool, rather than adapting PICO and an intervention-study checklist, to address this gap.

Practical application

Practical application

  1. The condition should be defined with sufficient precision to correspond to the way it is diagnosed or detected in the studies expected to be identified. A loosely defined condition will capture studies measuring subtly different phenomena, weakening any pooled estimate.
  2. Context should be treated as a filter on setting, geography and time period, not as a single keyword. Prevalence estimates vary substantially by setting and period, so Context requires active management throughout the search and appraisal process, not only at the question-framing stage.
  3. A prevalence-specific critical appraisal tool should be used rather than an intervention-study checklist. Sample-frame appropriateness, sampling method and handling of response rates are prevalence-specific quality criteria that an intervention checklist does not address.

Frequently asked questions

Yes; the same three elements, Condition, Context and Population, apply to incidence questions, which concern the rate of new cases over a period rather than the proportion of existing cases at a point in time, and the methodological guidance of Munn and colleagues explicitly covers both prevalence and incidence data.

Not for the core prevalence or incidence estimate; a comparator becomes relevant only if the broader purpose of the review is to compare prevalence across two defined groups, in which case the comparison is typically handled as two separate CoCoPoP-structured estimates rather than by adding a Comparison element to CoCoPoP.

Applying an intervention-study checklist to a prevalence study generates appraisal questions that cannot be meaningfully answered, such as questions about randomization in a study that was never comparative, and produces a misleading or uninformative quality assessment rather than a rigorous one.

PCC is a broader framework used for scoping reviews across many question types, in which Concept can represent almost any phenomenon of interest, whereas CoCoPoP is tailored specifically to prevalence and incidence questions, with Condition always referring to a measurable health state or phenomenon being quantified rather than to a broader concept.

References

  1. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. International Journal of Health Policy and Management. 2014;3(3):123-128. read 10 October 2026. View on IJHPM
  2. Joanna Briggs Institute. Checklist for Prevalence Studies. read 10 October 2026. View the JBI checklist (PDF)
  3. Song JW, Chung KC. Observational Studies: Cohort and Case-Control Studies. Plastic and Reconstructive Surgery. 2010;126(6):2234-2242. read 10 October 2026. View on PMC
  4. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. read 10 October 2026. View on The Lancet
  5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. read 10 October 2026. View on BMJ
  6. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP Journal Club. 1995;123(3):A12-A13. read 10 October 2026. View via DOI
  7. Booth A. Searching for qualitative research for inclusion in systematic reviews: a structured methodological review. Systematic Reviews. 2016;5:74. read 10 October 2026. View on Systematic Reviews
  8. Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qualitative Health Research. 2012;22(10):1435-1443. read 10 October 2026. View on PubMed
  9. Sterne JAC, Davey Smith G. Sifting the evidence-what's wrong with significance tests? BMJ. 2001;322(7280):226-231. read 10 October 2026. View on BMJ
  10. Farrugia P, Petrisor BA, Farrokhyar F, Bhandari M. Practical tips for surgical research: Research questions, hypotheses and objectives. Canadian Journal of Surgery. 2010;53(4):278-281. read 10 October 2026. View on PMC
  11. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare. 2015;13(3):147-153. read 13 November 2026. View via DOI
  12. Ehtesham N, Rafie MZ, Mosallaei M. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis. BMC Neurology. 2021;21(1):246. read 13 November 2026. View via DOI
  13. Camargo KM, Foster M, Buckingham B, McDonald TJ, Chiu WA. Characterizing baseline legacy chemical contamination in urban estuaries for disaster-research through systematic evidence mapping: a case study. Chemosphere. 2021;281:130925. read 13 November 2026. View via DOI
  14. Henriques M, Rodrigues D, Sacadura-Leite E, Viegas S, Serranheira F. Vitamin D status in the active duty Navy military personnel: protocol for a systematic review. BMJ Open. 2022;12(5):e060876. read 13 November 2026. View via DOI
  15. Videira S, Rodrigues MA, Santos J, Guedes J, Martins J, V da Silva M. Prevalence of the use of protective equipment for ionizing radiation from fluoroscopy: a systematic literature review and meta-analysis. Journal of Medical Imaging and Radiation Sciences. 2026;57(5):102465. read 13 November 2026. View via DOI
  16. Amoah LAO, Abbiw RK, Nartey NAN, Tetteh BE, Bugase E. Q fever in Africa: a systematic review of prevalence, zoonotic potential and disease burden. Public Health Challenges. 2026;5(3):e70323. read 13 November 2026. View via DOI
  17. Areri HA, Mengistu YT, Gary R. Chronic kidney disease screening practice among high-risk patients during follow-up in sub-Saharan Africa: a systematic review. Health Services Insights. 2026;19:11786329261468554. read 13 November 2026. View via DOI

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). The CoCoPoP Framework: Condition, Context and Population in Prevalence Reviews. Pubrica. https://pubrica.com/academy/concepts-definitions/cocopop-framework/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

CoCoPoP Question Worksheet

All three elements should be completed before a search and appraisal plan is developed for a prevalence or incidence review.

Condition (health state/phenomenon measured): ____________________
Context (setting, geography, time period): ____________________
Population (group measured within): ____________________
[ ] Checked Condition is defined to match how it was diagnosed/detected in expected studies
[ ] Treated Context as an active filter across the search and appraisal, not a one-time note
[ ] Selected a prevalence-specific critical appraisal tool rather than an intervention-study checklist
[ ] Decided upfront whether the review will meta-analyze a pooled estimate or synthesize descriptively

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

The Pubrica evidence synthesis team structures prevalence and incidence reviews using CoCoPoP and applies the dedicated prevalence appraisal criteria of the Joanna Briggs Institute, rather than imposing an intervention-study checklist on a question for which it was not designed.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Selection of an appropriate appraisal tool for prevalence reviews

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.